Quantcast

Latest autoimmune diseases Stories

2014-06-20 23:05:58

The aim of this webinar is to enable the end-user to select the best model and study design for their research utilising in vivo inflammatory bowel disease (IBD) models. The live broadcast will be taking place on Thursday, July 10, 2014 at 11 a.m. EDT / 4 p.m. BST (UK GMT +1). Toronto, Canada (PRWEB) June 20, 2014 This webinar is aimed at improving the end-users’ understanding of pre-clinical in vivo inflammatory bowel disease (IBD) models, addressing issues associated with the various...

Man With Hair-Loss Disease Gets New Growth Using Arthritis Drug
2014-06-19 15:21:48

Gerard LeBlond for redorbit.com - Your Universe Online Doctors at Yale University administered treatment for a non curable disease (alopecia universalis) in a 25-year-old man that left him without any hair. After the treatment, the man grew a full head of hair, eyebrows, eyelashes, armpit, facial and other hair on various parts of his body. His disease had not been previously treated and this was the first reported case with successful results. “The results are exactly what we...

2014-06-19 09:35:10

The JAMA Network Journals In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA. Tumor necrosis factor α (TNF-α)...

2014-06-19 04:21:28

DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ -- Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease. Apitope, through its innovative discovery platform, has selected three peptides...

2014-06-18 08:28:52

RALEIGH, N.C., June 18, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, will present a peer-reviewed poster relating to its highly selective sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate (a prodrug of active remogliflozin), at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine...

2014-06-18 08:28:40

~Expert panel shares tips, encouraging patients to take a 360° approach to managing their disease and to not give up until they're satisfied~

2014-06-17 23:16:13

Natural Lupus Treatment System is developed by Gary M Levin, who claims to teach people how to treat their lupus quickly and naturally. An overview on the website Vinaf.com shows if the program is worth buying. Tampa, FL (PRWEB) June 17, 2014 Natural Lupus Treatment System is the latest program that provides people natural remedies, techniques, tips, and detailed instructions on how treat their lupus. In the program, people will discover all important information about lupus such as...

2014-06-17 23:07:06

There is no correlation between the consumption of a cow’s milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide research study published in the Journal of the American Medical Association (JAMA). Atlanta, Georgia (PRWEB) June 17, 2014 There is no correlation between the consumption of a cow’s milk-based formula or hydrolyzed protein formula and the development of...

2014-06-16 13:03:46

University of Melbourne New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne-lead study successfully mapped the genes of a parasitic worm in pigs New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of Melbourne – lead study successfully mapped the genes of a...

2014-06-16 12:29:02

DEERFIELD, Ill., and OSAKA, Japan, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the United States (U.S.) commercial availability of a new biologic therapy, ENTYVIO((TM) )(vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD). "We understand how a great need still exists for additional treatment options...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related